Steadying influence for neurons identified.
Barinaga
M
M
D000200:Action Potentials; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects / Q000502:physiology; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D051658:KCNQ2 Potassium Channel; D051659:KCNQ3 Potassium Channel; D009474:Neurons / Q000502:physiology*; D011188:Potassium / Q000378:metabolism; D015221:Potassium Channels / Q000737:chemistry* / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D024642:Potassium Channels, Voltage-Gated; D013564:Sympathetic Nervous System / Q000166:cytology
D000927:Anticonvulsants; D051658:KCNQ2 Potassium Channel; C496914:KCNQ2 protein, human; D051659:KCNQ3 Potassium Channel; C496916:KCNQ3 protein, human; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D011188:Potassium